Are Cases Containing Combination Products Represented Differently in the NDA Listing? (Doc ID 2957293.1)

Last updated on JULY 31, 2023

Applies to:

Oracle Life Sciences Argus Safety - Version 8.2.3.1 and later
Information in this document applies to any platform.

Have changes been made to the New Drug Application (NDA) report in Argus to represent cases containing combination products?

	To view full details, sign in with your My Oracle Support account.
	Don't have a My Oracle Support account? Click to get started!

In this Document

Goal

My Oracle Support provides customers with access to over a million knowledge articles and a vibrant support community of peers and Oracle experts.